Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (4) , 404-409
- https://doi.org/10.1016/s0002-9149(99)00324-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Antiplatelet Effects of Ticlopidine and ClopidogrelAnnals of Internal Medicine, 1998
- Should Thrombolysis or Primary Angioplasty Be the Treatment of Choice for Acute Myocardial Infarction?New England Journal of Medicine, 1996
- Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Dose Effects of Aspirin on Gastric Prostaglandins and Stomach Mucosal InjuryAnnals of Internal Medicine, 1994
- Thrombolysis in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.Circulation, 1993
- Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young menThe American Journal of Cardiology, 1992
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984